View in EDS HTML Full Text PDF Full Text

Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.

Saved in:
Bibliographic Details
Title: Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
Authors: Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tisza V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary., Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Lgo R. Benzi 10, 16132, Italy., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Pataki B; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Ribli D; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Sztupinszki Z; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Rohanizadegan M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Stillman DR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Alaiwi SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Bartels AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Papp M; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary.; Centre for Bioinformatics, University of Veterinary Medicine, Istvan str. 2, Budapest, 1078, Hungary., Shetty A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA., Abbasi F; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lin X; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lawrenson K; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Gayther SA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Baca S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Solymosi N; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Csabai I; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Szallasi Z; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Department of Bioinformatics, Forensic and Insurance Medicine Semmelweis University, Budapest, Hungary.; Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.; National Korányi Institute of Pulmonology, Budapest, 1112, Hungary., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA. matthew_freedman@dfci.harvard.edu.
Source: Nature communications [Nat Commun] 2023 Oct 19; Vol. 14 (1), pp. 6623. Date of Electronic Publication: 2023 Oct 19.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37857693
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spisak+S%22">Spisak S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Tisza+V%22">Tisza V</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary.<br /><searchLink fieldCode="AU" term="%22Nuzzo+PV%22">Nuzzo PV</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Lgo R. Benzi 10, 16132, Italy.<br /><searchLink fieldCode="AU" term="%22Seo+JH%22">Seo JH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Pataki+B%22">Pataki B</searchLink>; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.<br /><searchLink fieldCode="AU" term="%22Ribli+D%22">Ribli D</searchLink>; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.<br /><searchLink fieldCode="AU" term="%22Sztupinszki+Z%22">Sztupinszki Z</searchLink>; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Bell+C%22">Bell C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Rohanizadegan+M%22">Rohanizadegan M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Stillman+DR%22">Stillman DR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Alaiwi+SA%22">Alaiwi SA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Bartels+AH%22">Bartels AH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Papp+M%22">Papp M</searchLink>; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary.; Centre for Bioinformatics, University of Veterinary Medicine, Istvan str. 2, Budapest, 1078, Hungary.<br /><searchLink fieldCode="AU" term="%22Shetty+A%22">Shetty A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Abbasi+F%22">Abbasi F</searchLink>; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.<br /><searchLink fieldCode="AU" term="%22Lin+X%22">Lin X</searchLink>; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.<br /><searchLink fieldCode="AU" term="%22Lawrenson+K%22">Lawrenson K</searchLink>; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.<br /><searchLink fieldCode="AU" term="%22Gayther+SA%22">Gayther SA</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.<br /><searchLink fieldCode="AU" term="%22Pomerantz+M%22">Pomerantz M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Baca+S%22">Baca S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Solymosi+N%22">Solymosi N</searchLink>; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.<br /><searchLink fieldCode="AU" term="%22Csabai+I%22">Csabai I</searchLink>; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.<br /><searchLink fieldCode="AU" term="%22Szallasi+Z%22">Szallasi Z</searchLink>; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Department of Bioinformatics, Forensic and Insurance Medicine Semmelweis University, Budapest, Hungary.; Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.; National Korányi Institute of Pulmonology, Budapest, 1112, Hungary.<br /><searchLink fieldCode="AU" term="%22Gusev+A%22">Gusev A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Freedman+ML%22">Freedman ML</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA. matthew_freedman@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Oct 19; Vol. 14 (1), pp. 6623. <i>Date of Electronic Publication: </i>2023 Oct 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37857693
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-023-42515-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6623
    Titles:
      – TitleFull: Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spisak S
      – PersonEntity:
          Name:
            NameFull: Tisza V
      – PersonEntity:
          Name:
            NameFull: Nuzzo PV
      – PersonEntity:
          Name:
            NameFull: Seo JH
      – PersonEntity:
          Name:
            NameFull: Pataki B
      – PersonEntity:
          Name:
            NameFull: Ribli D
      – PersonEntity:
          Name:
            NameFull: Sztupinszki Z
      – PersonEntity:
          Name:
            NameFull: Bell C
      – PersonEntity:
          Name:
            NameFull: Rohanizadegan M
      – PersonEntity:
          Name:
            NameFull: Stillman DR
      – PersonEntity:
          Name:
            NameFull: Alaiwi SA
      – PersonEntity:
          Name:
            NameFull: Bartels AH
      – PersonEntity:
          Name:
            NameFull: Papp M
      – PersonEntity:
          Name:
            NameFull: Shetty A
      – PersonEntity:
          Name:
            NameFull: Abbasi F
      – PersonEntity:
          Name:
            NameFull: Lin X
      – PersonEntity:
          Name:
            NameFull: Lawrenson K
      – PersonEntity:
          Name:
            NameFull: Gayther SA
      – PersonEntity:
          Name:
            NameFull: Pomerantz M
      – PersonEntity:
          Name:
            NameFull: Baca S
      – PersonEntity:
          Name:
            NameFull: Solymosi N
      – PersonEntity:
          Name:
            NameFull: Csabai I
      – PersonEntity:
          Name:
            NameFull: Szallasi Z
      – PersonEntity:
          Name:
            NameFull: Gusev A
      – PersonEntity:
          Name:
            NameFull: Freedman ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 10
              Text: 2023 Oct 19
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1